Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Vaxil Bio Ltd. Proxy Solicitation & Information Statement 2024

Oct 3, 2024

46554_rns_2024-10-03_add9d0ca-7fb3-4cfd-88c3-0e0e7ec9b10c.pdf

Proxy Solicitation & Information Statement

Open in viewer

Opens in your device viewer

October 3, 2024

==> picture [201 x 45] intentionally omitted <==

Filed via SEDAR+

To All Applicable Exchanges and Securities Administrators

Subject: Vaxil Bio Ltd. (the "Issuer") Notice of Meeting and Record Date

Dear Sir/Madam:

We are pleased to confirm the following information with respect to the Issuer's upcoming meeting of securityholders:

MeetingType: Annual Special Meeting
MeetingDate: December 12,2024
Record Date for Notice of Meeting: October 28,2024
Record Date for Voting (if applicable): October 28,2024
Beneficial OwnershipDetermination Date: October 28,2024
Class of Securities Entitled to Vote: Common Shares
ISIN: CA92243L1076
Issuer sending proxymaterials directlyto NOBOs: No
Issuerpayingfor deliveryto OBOs: No
Notice and Access for Beneficial Holders: Yes
Beneficial Holders Stratification Criteria: N/A
Notice and Access for Registered Holders: No

In accordance with applicable securities regulations we are filing this information with you in our capacity as agent of the Issuer.

Yours truly,

Odyssey Trust Company as agent for Vaxil Bio Ltd.